+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Invokana"

Russia Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Russia Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Russia
From
Australia Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Australia Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Australia
From
Japan Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Japan Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Japan
From
North America Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

North America Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 75 Pages
  • North America
From
Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 70 Pages
  • Latin America
From
Middle-East and Africa Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Middle-East and Africa Diabetes Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • October 2022
  • 70 Pages
  • Africa
From
Diabetic Nephropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Diabetic Nephropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • May 2024
  • 213 Pages
  • Global
From
Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Type 2 Diabete Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • September 2025
  • 142 Pages
  • Global
From
SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

SGLT2 Inhibitors Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 87 Pages
  • Global
From
SGLT2 Inhibitors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

SGLT2 Inhibitors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • May 2025
  • 132 Pages
  • Global
From
Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction - Product Thumbnail Image

Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction

  • Report
  • January 2024
  • 120 Pages
  • United States
Loading Indicator

Invokana is a prescription medication used to treat type 2 diabetes, a chronic endocrine and metabolic disorder. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose by the kidneys, allowing it to be eliminated in the urine. Invokana is taken orally once a day and is typically used in combination with diet and exercise to improve glycemic control. It is also used to reduce the risk of cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. Invokana is marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies in the market include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, and Sanofi. Show Less Read more